AKRO

Akero Therapeutics INC

-$4.4B

Net Activity

Institutions Holding

2

Popularity Rank

#15996

Avg Weight

0.00%

Total Value

$533.0K

Ownership Trend

2 institutions currently hold AKRO, with 1 net buyers and 262 net sellers this quarter.

Institutional Moves

Institutional Moves (Q4 2025)

Significantly Decreased

Based on recent trading activity

Net Selling Institutions

262

Net Buying Institutions

1

Key Holders

View all 2 holding institutions

Quarterly Activity

Recent Activity

+$984.0

Total Buy Value

$4.4B

Total Sell Value

New buy0
Trim0
Add1
Sold out262

1

Net Buyers

262

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AKERO THERAPEUTICS INC (AKRO)?
Major stakeholders currently include DekaBank Deutsche Girozentrale ($532.0K), IFP Advisors, Inc ($984.0). Based on the latest 13F filings, there are a total of 2 tracked investment funds and institutions maintaining positions in AKRO.
What is the overall institutional sentiment toward AKRO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $4.4B, driven by 1 managers accumulating shares while 262 reduced their exposure.
Which institutions have been selling or reducing their AKRO positions?
In the latest period, 0 funds trimmed their holdings, and 262 managers completely exited their positions. The aggregate reported sell value was $4.4B.
Are there any notable investors adding AKRO to their portfolios?
Yes, buying activity remains notable. 0 institutions opened new positions in {ticker}, and 1 existing holders added to their shares. The total reported buy value for the quarter amounted to $984.0.

Related Stocks